Arrowhead Pharmaceuticals (ARWR) earnings

Earnings (net income) · fiscal 2026
-$724.21M

Arrowhead Pharmaceuticals (ARWR) reported net income of -$724.21M in fiscal 2026 (the year ended September 30, 2026). In fiscal 2025 the figure was -$1.63M. Figures as of 18 Nov 2026, 04:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2026
-$724.21M
Highest on record
$67.98Mfiscal 2019
Lowest on record
-$724.21Mfiscal 2026
Fiscal years on record
242003–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arrowhead Pharmaceuticals earnings, in more detail

Across the 24 fiscal years on record (2003–2026), the highest was $67.98M in fiscal 2019 and the lowest -$724.21M in fiscal 2026.

History · 24 fiscal years

Earnings (net income) by fiscal year

Arrowhead Pharmaceuticals earnings, year by year

Arrowhead Pharmaceuticals (ARWR) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2026-$724.21M—
2025-$1.63M—
2024-$599.49M—
2023-$205.28M—
2022-$176.06M—
2021-$140.85M—
2020-$84.55M 224.4% down
2019$67.98M—
2018-$54.45M—
2017-$34.38M—
2016-$81.72M—
2015-$91.94M—
2014-$58.63M—
2013-$31.14M—
2012-$21.13M—
2011-$3.13M—
2010-$5.77M—
2009-$19.31M—
2008-$27.24M—
2007-$30.71M—
2006-$19.96M—
2005-$6.73M—
2004-$751.26K—
2003-$95.24K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Arrowhead Pharmaceuticals and comparable companies
CompanyEarnings (net income)Fiscal year
Axsome Therapeutics AXSM-$183.17M2025
Chemed CHE$265.24M2025
Oruka Therapeutics ORKA-$105.43M2025
Arrowhead Pharmaceuticals ARWR-$724.21M2026
MSA Safety MSA$278.92M2025
CG Oncology CGON-$161.00M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ARWR

Arrowhead Pharmaceuticals, figure by figure

Arrowhead Pharmaceuticals (ARWR) overview: price, valuation and scorecardAll health care companies by market value

Arrowhead Pharmaceuticals earnings: questions and answers

What is Arrowhead Pharmaceuticals's net income?

Arrowhead Pharmaceuticals (ARWR) reported net income of -$724.21M in fiscal 2026 (the year ended September 30, 2026). In fiscal 2025 the figure was -$1.63M.

What are the highest and lowest net income figures on record for Arrowhead Pharmaceuticals?

Across the 24 fiscal years on record (2003–2026), the highest was $67.98M in fiscal 2019 and the lowest -$724.21M in fiscal 2026.

How is Arrowhead Pharmaceuticals's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arrowhead Pharmaceuticals (ARWR) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/ARWR/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.